All In Biotech

Drug Trial Radar · NCT06726395

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Randomized Controlled Clinical Trial Comparing Treatment With Cloxacillin Versus Benzylpenicillin in Bacteraemia Caused by Penicillin-susceptible Staphylococcus Aureus (PSSA)

Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 420 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

420

Planned (sponsor's estimate)

Start

Mar 10, 2025

Primary completion

Apr 2028

Study completion Jul 2028

Sponsor

Lead sponsor
Region SkaneAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 10, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to investigate if benzylpenicillin is a better treatment option than cloxacillin in patients with penicillin-susceptible Staphylococcus aureus bacteraemia.

Conditions

  • Staphylococcus Aureus Bacteraemia
  • Staphylococcal Bacteraemia
  • Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)
  • Staphylococcus (S.) Aureus Infection

Interventions

  • Penicillin G_1200mgDrug

    benzylpenicillin preferred dosing 1gx4

  • cloxacillinDrug

    cloxacillin 2gx4

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival at 90 days without any treatment complicationsTime frame: From enrollment to 90 days after end of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Skånes universitetssjukhus, Region Skåne

    Lund, Sweden · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.